{"pmid":32240762,"title":"Nervous system involvement after infection with COVID-19 and other coronaviruses.","text":["Nervous system involvement after infection with COVID-19 and other coronaviruses.","Viral infections have detrimental impacts on neurological functions, and even to cause severe neurological damage. Very recently, coronaviruses (CoV), especially severe acute respiratory syndrome CoV 2 (SARS-CoV-2), exhibit neurotropic properties and may also cause neurological diseases. It is reported that CoV can be found in the brain or cerebrospinal fluid. The pathobiology of these neuroinvasive viruses is still incompletely known, and it is therefore important to explore the impact of CoV infections on the nervous system. Here, we review the research into neurological complications in CoV infections and the possible mechanisms of damage to the nervous system.","Brain Behav Immun","Wu, Yeshun","Xu, Xiaolin","Chen, Zijun","Duan, Jiahao","Hashimoto, Kenji","Yang, Ling","Liu, Cunming","Yang, Chun","32240762"],"abstract":["Viral infections have detrimental impacts on neurological functions, and even to cause severe neurological damage. Very recently, coronaviruses (CoV), especially severe acute respiratory syndrome CoV 2 (SARS-CoV-2), exhibit neurotropic properties and may also cause neurological diseases. It is reported that CoV can be found in the brain or cerebrospinal fluid. The pathobiology of these neuroinvasive viruses is still incompletely known, and it is therefore important to explore the impact of CoV infections on the nervous system. Here, we review the research into neurological complications in CoV infections and the possible mechanisms of damage to the nervous system."],"journal":"Brain Behav Immun","authors":["Wu, Yeshun","Xu, Xiaolin","Chen, Zijun","Duan, Jiahao","Hashimoto, Kenji","Yang, Ling","Liu, Cunming","Yang, Chun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240762","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.bbi.2020.03.031","keywords":["COVID-19","Coronaviruses infection","Mechanisms","Nervous system"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1662996001865072641,"score":7.6048946,"similar":[{"pmid":32238438,"title":"Does COVID19 infect the brain? If so, smokers might be at a higher risk.","text":["Does COVID19 infect the brain? If so, smokers might be at a higher risk.","COVID19 is a devastating global pandemic with epicenters in China, Italy, Spain, and now the United States. While the majority of infected cases appear mild, in some cases individuals present serious cardiorespiratory complications with possible long-term lung damage. Infected individuals report a range of symptoms from headaches to shortness of breath to taste and smell loss. To that end, less is known about the how the virus may impact different organ systems. The SARS-CoV2 virus, which is responsible for COVID19, is highly similar to SARS-CoV. Both viruses have evolved an ability to enter host cells through direct interaction with the angiotensin converting enzyme 2 (ACE2) protein at the surface of many cells. Published findings indicate that SARS-CoV can enter the human nervous system with evidence from both postmortem brains and detection in cerebrospinal fluid of infected individuals. Here we consider the ability of SARS-CoV2 to enter and infect the human nervous system based on the strong expression of the ACE2 target throughout the brain. Moreover, we predict that nicotine exposure through various kinds of smoking (cigarettes, e-cigarettes, or vape) can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2. We advocate for higher surveillance and analysis of neuro-complications in infected cases.","Mol Pharmacol","Kabbani, Nadine","Olds, James L","32238438"],"abstract":["COVID19 is a devastating global pandemic with epicenters in China, Italy, Spain, and now the United States. While the majority of infected cases appear mild, in some cases individuals present serious cardiorespiratory complications with possible long-term lung damage. Infected individuals report a range of symptoms from headaches to shortness of breath to taste and smell loss. To that end, less is known about the how the virus may impact different organ systems. The SARS-CoV2 virus, which is responsible for COVID19, is highly similar to SARS-CoV. Both viruses have evolved an ability to enter host cells through direct interaction with the angiotensin converting enzyme 2 (ACE2) protein at the surface of many cells. Published findings indicate that SARS-CoV can enter the human nervous system with evidence from both postmortem brains and detection in cerebrospinal fluid of infected individuals. Here we consider the ability of SARS-CoV2 to enter and infect the human nervous system based on the strong expression of the ACE2 target throughout the brain. Moreover, we predict that nicotine exposure through various kinds of smoking (cigarettes, e-cigarettes, or vape) can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2. We advocate for higher surveillance and analysis of neuro-complications in infected cases."],"journal":"Mol Pharmacol","authors":["Kabbani, Nadine","Olds, James L"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238438","week":"202014|Mar 30 - Apr 05","doi":"10.1124/molpharm.120.000014","keywords":["Neuroinflammation","angiotensin converting enzyme (ACE)","infection","nicotine","nicotinic acetylcholine receptors"],"source":"PubMed","locations":["China","United States","Spain","Italy"],"countries":["China","Italy","United States","Spain"],"countries_codes":["CHN|China","ITA|Italy","USA|United States","ESP|Spain"],"topics":["Mechanism"],"weight":1,"_version_":1662996001903869953,"score":327.5245},{"pmid":32104915,"title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","text":["The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure.","J Med Virol","Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu","32104915"],"abstract":["Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure."],"journal":"J Med Virol","authors":["Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104915","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25728","keywords":["cell susceptibility","coronavirus","dissemination","nervous system"],"source":"PubMed","locations":["China","SARS-CoV","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663095626144940032,"score":324.7581},{"pmid":32167747,"pmcid":"PMC7094171","title":"Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.","text":["Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.","The recent outbreak of coronavirus infectious disease 2019 (COVID-19) has gripped the world with apprehension and has evoked a scare of epic proportion regarding its potential to spread and infect humans worldwide. As we are in the midst of an ongoing pandemic of COVID-19, scientists are struggling to understand how it resembles and differs from the severe acute respiratory syndrome coronavirus (SARS-CoV) at the genomic and transcriptomic level. In a short time following the outbreak, it has been shown that, similar to SARS-CoV, COVID-19 virus exploits the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry inside the cells. This finding raises the curiosity of investigating the expression of ACE2 in neurological tissue and determining the possible contribution of neurological tissue damage to the morbidity and mortality caused by COIVD-19. Here, we investigate the density of the expression levels of ACE2 in the CNS, the host-virus interaction and relate it to the pathogenesis and complications seen in the recent cases resulting from the COVID-19 outbreak. Also, we debate the need for a model for staging COVID-19 based on neurological tissue involvement.","ACS Chem Neurosci","Baig, Abdul Mannan","Khaleeq, Areeba","Ali, Usman","Syeda, Hira","32167747"],"abstract":["The recent outbreak of coronavirus infectious disease 2019 (COVID-19) has gripped the world with apprehension and has evoked a scare of epic proportion regarding its potential to spread and infect humans worldwide. As we are in the midst of an ongoing pandemic of COVID-19, scientists are struggling to understand how it resembles and differs from the severe acute respiratory syndrome coronavirus (SARS-CoV) at the genomic and transcriptomic level. In a short time following the outbreak, it has been shown that, similar to SARS-CoV, COVID-19 virus exploits the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry inside the cells. This finding raises the curiosity of investigating the expression of ACE2 in neurological tissue and determining the possible contribution of neurological tissue damage to the morbidity and mortality caused by COIVD-19. Here, we investigate the density of the expression levels of ACE2 in the CNS, the host-virus interaction and relate it to the pathogenesis and complications seen in the recent cases resulting from the COVID-19 outbreak. Also, we debate the need for a model for staging COVID-19 based on neurological tissue involvement."],"journal":"ACS Chem Neurosci","authors":["Baig, Abdul Mannan","Khaleeq, Areeba","Ali, Usman","Syeda, Hira"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32167747","week":"202011|Mar 09 - Mar 15","doi":"10.1021/acschemneuro.0c00122","keywords":["ACE2 tissue distribution","COVID-19","Coronavirus","SARS-CoV-2","host-virus interaction","spike protein"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663095625984507904,"score":320.7732},{"pmid":32243596,"title":"Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.","text":["Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.","We have read with interest the paper by Li and colleagues about the neurotropism of the severe acute respiratory syndrome coronavirus (SARS-CoV-2), responsible of coronavirus disease (COVID-19), recently discovered in China and now worldwide spread.(1) In particular, the paper focuses on the role of the nervous system involvement in causing the respiratory failure. This article is protected by copyright. All rights reserved.","J Med Virol","Coraci, Daniele","Fusco, Augusto","Frizziero, Antonio","Giovannini, Silvia","Biscotti, Lorenzo","Padua, Luca","32243596"],"abstract":["We have read with interest the paper by Li and colleagues about the neurotropism of the severe acute respiratory syndrome coronavirus (SARS-CoV-2), responsible of coronavirus disease (COVID-19), recently discovered in China and now worldwide spread.(1) In particular, the paper focuses on the role of the nervous system involvement in causing the respiratory failure. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Coraci, Daniele","Fusco, Augusto","Frizziero, Antonio","Giovannini, Silvia","Biscotti, Lorenzo","Padua, Luca"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243596","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25829","keywords":["Coronavirus","Nervous system","Public policy"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663079112813576193,"score":230.75194},{"pmid":32246782,"title":"Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.","text":["Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.","Many viruses can occasionally gain entry into the human central nervous system (CNS), even if most of the disease they cause does not involve the CNS. In a recent review, Li and colleagues (J Med Virol doi: 10.1002/jmv.25728) propose that SARS coronavirus-2 (SARS-CoV-2) can enter the human CNS, based upon the observation that a number of patients need mechanical ventilation to treat respiratory failure. However, respiratory failure caused by pneumonia is clinically distinct from that caused by brain failure. The published clinical features of COVID-19 do not suggest that involvement of the CNS is common. The possibility of CNS entry by SARS-CoV-2 remains plausible, but unproven. This article is protected by copyright. All rights reserved.","J Med Virol","Turtle, Lance","32246782"],"abstract":["Many viruses can occasionally gain entry into the human central nervous system (CNS), even if most of the disease they cause does not involve the CNS. In a recent review, Li and colleagues (J Med Virol doi: 10.1002/jmv.25728) propose that SARS coronavirus-2 (SARS-CoV-2) can enter the human CNS, based upon the observation that a number of patients need mechanical ventilation to treat respiratory failure. However, respiratory failure caused by pneumonia is clinically distinct from that caused by brain failure. The published clinical features of COVID-19 do not suggest that involvement of the CNS is common. The possibility of CNS entry by SARS-CoV-2 remains plausible, but unproven. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Turtle, Lance"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246782","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25828","keywords":["COVID","COVID-19","Coronavirus","SARS coronavirus-2","SARS-CoV-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663169699639197697,"score":217.08847}]}